RTX (NYSE: RTX) faces challenges in 2026 due to a pause in buyback activity mandated by a January executive order from President Trump, which targets defense contractors like RTX that are underperforming on military contracts. Despite this, the company shows healthy growth, with a net revenue of $22.1 billion in Q1 2026, marking a nearly 9% increase and surpassing estimates by 300 basis points. Analysts project a moderate buy consensus with an 8% upside, potentially reaching $240, while institutional investors own about 87% of the shares and are consistently accumulating.
RTX’s dividend yields approximately 1.4%, backed by a 50% earnings payout ratio. The solid financial metrics suggest reliability, bolstered by five consecutive annual increases in dividends. However, the risk remains that performance on defense contracts could trigger further regulatory scrutiny. The company’s backlog is significant, estimated at $271 million, or over 10 quarters of revenue based on Q1 performance, indicating the need for effective execution to translate guidance into actual results.
With a critical support level around $190, the stock may consolidate within its trading range amidst overall market fluctuations. The short-term 30-day exponential moving average indicates rising bullish activity, positioning RTX for potential upward movement if market conditions improve.
